{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T20:10:46Z","timestamp":1788725446900,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jiangsu Funding Program for Excellent Postdoctoral Talent","award":["2022ZB746"],"award-info":[{"award-number":["2022ZB746"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02354-y","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:14:48Z","timestamp":1788606888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative omics profiling of CRELD2 in ccRCC: a nexus of genetics, prognosis, and tumor microenvironment"],"prefix":"10.1007","volume":"75","author":[{"given":"Shouyong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenquan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"issue":"10451","key":"2354_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0140-6736(24)00917-6","volume":"404","author":"M Young","year":"2024","unstructured":"Young M, Jackson-Spence F, Beltran L, Day E, Suarez C, Bex A, Powles T, Szabados B. Renal cell carcinoma. Lancet. 2024;404(10451):476\u201391.","journal-title":"Lancet"},{"issue":"1","key":"2354_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","volume":"75","author":"U Capitanio","year":"2019","unstructured":"Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, Gore JL, Sun M, Wood C, Russo P. Epidemiology of renal cell carcinoma. Eur Urol. 2019;75(1):74\u201384.","journal-title":"Eur Urol"},{"issue":"4","key":"2354_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","volume":"17","author":"E Jonasch","year":"2021","unstructured":"Jonasch E, Walker CL, Rathmell WK. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nat Rev Nephrol. 2021;17(4):245\u201361.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"2354_CR4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-024-02059-y","volume":"23","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Jin Y, Zhou J, Chen F, Chen M, Gao Z, Hu L, Xuan J, Li X, Song Z, et al. PD1\/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives. Mol Cancer. 2024;23(1):146.","journal-title":"Mol Cancer"},{"issue":"10","key":"2354_CR5","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.3390\/biomedicines10102583","volume":"10","author":"M Matuszczak","year":"2022","unstructured":"Matuszczak M, Kilja\u0144czyk A, Salagierski M. The role of focal therapy and active surveillance for small renal mass therapy. Biomedicines. 2022;10(10):2583.","journal-title":"Biomedicines"},{"issue":"2","key":"2354_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1001\/jamaoncol.2023.5269","volume":"10","author":"A Ghoreifi","year":"2024","unstructured":"Ghoreifi A, Vaishampayan U, Yin M, Psutka SP, Djaladat H. Immune checkpoint inhibitor therapy before nephrectomy for locally advanced and metastatic renal cell carcinoma: a review. JAMA Oncol. 2024;10(2):240\u20138.","journal-title":"JAMA Oncol"},{"issue":"6","key":"2354_CR7","first-page":"507","volume":"67","author":"PC Barata","year":"2017","unstructured":"Barata PC, Rini BI. Treatment of renal cell carcinoma: current status and future directions. CA Cancer J Clin. 2017;67(6):507\u201324.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2354_CR8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMra1601333","volume":"376","author":"TK Choueiri","year":"2017","unstructured":"Choueiri TK, Motzer RJ. Systemic therapy for metastatic renal-cell carcinoma. N Engl J Med. 2017;376(4):354\u201366.","journal-title":"N Engl J Med"},{"issue":"3","key":"2354_CR9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.bbrc.2009.07.047","volume":"387","author":"K Oh-hashi","year":"2009","unstructured":"Oh-hashi K, Koga H, Ikeda S, Shimada K, Hirata Y, Kiuchi K. CRELD2 is a novel endoplasmic reticulum stress-inducible gene. Biochem Biophys Res Commun. 2009;387(3):504\u201310.","journal-title":"Biochem Biophys Res Commun"},{"issue":"15","key":"2354_CR10","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/j.febslet.2011.06.029","volume":"585","author":"K Oh-hashi","year":"2011","unstructured":"Oh-hashi K, Kunieda R, Hirata Y, Kiuchi K. Biosynthesis and secretion of mouse cysteine-rich with EGF-like domains 2. FEBS Lett. 2011;585(15):2481\u20137.","journal-title":"FEBS Lett"},{"issue":"10","key":"2354_CR11","doi-asserted-by":"publisher","first-page":"e21939","DOI":"10.1096\/fj.202002713RR","volume":"35","author":"P Kern","year":"2021","unstructured":"Kern P, Balzer NR, Blank N, Cygon C, Wunderling K, Bender F, Frolov A, Sowa JP, Bonaguro L, Ulas T, et al. Creld2 function during unfolded protein response is essential for liver metabolism homeostasis. Faseb j. 2021;35(10):e21939.","journal-title":"Faseb j"},{"issue":"2","key":"2354_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/toxsci\/kfs203","volume":"129","author":"K Nohara","year":"2012","unstructured":"Nohara K, Tateishi Y, Suzuki T, Okamura K, Murai H, Takumi S, Maekawa F, Nishimura N, Kobori M, Ito T. Late-onset increases in oxidative stress and other tumorigenic activities and tumors with a Ha-ras mutation in the liver of adult male C3H mice gestationally exposed to arsenic. Toxicol Sci. 2012;129(2):293\u2013304.","journal-title":"Toxicol Sci"},{"key":"2354_CR13","doi-asserted-by":"publisher","first-page":"174903","DOI":"10.1016\/j.ejphar.2022.174903","volume":"922","author":"SY Lee","year":"2022","unstructured":"Lee SY, Wong PF, Jamal J, Roebuck MM. Naturally-derived endoplasmic reticulum stress inhibitors for osteoarthritis? Eur J Pharmacol. 2022;922:174903.","journal-title":"Eur J Pharmacol"},{"key":"2354_CR14","doi-asserted-by":"publisher","first-page":"109880","DOI":"10.1016\/j.cellsig.2020.109880","volume":"78","author":"Y Rellmann","year":"2021","unstructured":"Rellmann Y, Eidhof E, Dreier R. Review: ER stress-induced cell death in osteoarthritic cartilage. Cell Signal. 2021;78:109880.","journal-title":"Cell Signal"},{"issue":"25","key":"2354_CR15","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.1093\/hmg\/ddt383","volume":"22","author":"CL Hartley","year":"2013","unstructured":"Hartley CL, Edwards S, Mullan L, Bell PA, Fresquet M, Boot-Handford RP, Briggs MD. Armet\/Manf and Creld2 are components of a specialized ER stress response provoked by inappropriate formation of disulphide bonds: implications for genetic skeletal diseases. Hum Mol Genet. 2013;22(25):5262\u201375.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2354_CR16","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1248\/bpb.b14-00825","volume":"38","author":"K Oh-hashi","year":"2015","unstructured":"Oh-hashi K, Norisada J, Hirata Y, Kiuchi K. Characterization of the Role of MANF in Regulating the Secretion of CRELD2. Biol Pharm Bull. 2015;38(5):722\u201331.","journal-title":"Biol Pharm Bull"},{"issue":"12","key":"2354_CR17","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/cm.21894","volume":"81","author":"A Pittar","year":"2024","unstructured":"Pittar A, Buckley EJ, Boyle ST, Ibbetson SJ, Samuel MS. Enhanced RHO-ROCK signaling is associated with CRELD2 production and fibroblast recruitment in cutaneous squamous cell carcinoma. Cytoskeleton (Hoboken). 2024;81(12):864\u201371.","journal-title":"Cytoskeleton (Hoboken)"},{"key":"2354_CR18","doi-asserted-by":"publisher","first-page":"998792","DOI":"10.3389\/fgene.2022.998792","volume":"13","author":"Y Gao","year":"2022","unstructured":"Gao Y, Hou Q, Guo R, Ying J, Xiong J, Jiang H. Effect of Sun exposure-induced ferroptosis mechanisms on pathology and potential biological processes of primary melanoma by microarray data analysis. Front Genet. 2022;13:998792.","journal-title":"Front Genet"},{"issue":"7","key":"2354_CR19","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/s41556-020-0523-y","volume":"22","author":"ST Boyle","year":"2020","unstructured":"Boyle ST, Poltavets V, Kular J, Pyne NT, Sandow JJ, Lewis AC, Murphy KJ, Kolesnikoff N, Moretti PAB, Tea MN, et al. ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through a CRELD2-dependent mechanism. Nat Cell Biol. 2020;22(7):882\u201395.","journal-title":"Nat Cell Biol"},{"issue":"11","key":"2354_CR20","doi-asserted-by":"publisher","first-page":"152510","DOI":"10.1016\/j.prp.2019.152510","volume":"215","author":"GM Liu","year":"2019","unstructured":"Liu GM, Zeng HD, Zhang CY, Xu JW. Key genes associated with diabetes mellitus and hepatocellular carcinoma. Pathol Res Pract. 2019;215(11):152510.","journal-title":"Pathol Res Pract"},{"key":"2354_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","volume":"4","author":"S Burgess","year":"2019","unstructured":"Burgess S, Davey Smith G, Davies NM, Dudbridge F, Gill D, Glymour MM, Hartwig FP, Kutalik Z, Holmes MV, Minelli C, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2019;4:186.","journal-title":"Wellcome Open Res"},{"key":"2354_CR22","doi-asserted-by":"publisher","first-page":"n2233","DOI":"10.1136\/bmj.n2233","volume":"375","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ, Timpson NJ, Higgins JPT, Dimou N, Langenberg C, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ. 2021;375:n2233.","journal-title":"BMJ"},{"key":"2354_CR23","doi-asserted-by":"publisher","first-page":"1343512","DOI":"10.3389\/fimmu.2024.1343512","volume":"15","author":"YX Wang","year":"2024","unstructured":"Wang YX, Zhou CP, Wang DT, Ma J, Sun XH, Wang Y, Zhang YM. Unraveling the causal role of immune cells in gastrointestinal tract cancers: insights from a Mendelian randomization study. Front Immunol. 2024;15:1343512.","journal-title":"Front Immunol"},{"issue":"1","key":"2354_CR24","doi-asserted-by":"publisher","first-page":"e28162","DOI":"10.1002\/jmv.28162","volume":"95","author":"S Krishnamoorthy","year":"2023","unstructured":"Krishnamoorthy S, Li GH, Cheung CL. Transcriptome-wide summary data-based Mendelian randomization analysis reveals 38 novel genes associated with severe COVID-19. J Med Virol. 2023;95(1):e28162.","journal-title":"J Med Virol"},{"issue":"4","key":"2354_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/1744666X.2023.2295987","volume":"20","author":"B Ran","year":"2024","unstructured":"Ran B, Qin J, Wu Y, Wen F. Causal role of immune cells in chronic obstructive pulmonary disease: Mendelian randomization study. Expert Rev Clin Immunol. 2024;20(4):413\u201321.","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"2354_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12943-023-01859-y","volume":"22","author":"M Liao","year":"2023","unstructured":"Liao M, Sun X, Zheng W, Wu M, Wang Y, Yao J, Ma Y, Gao S, Pei D. LINC00922 decoys SIRT3 to facilitate the metastasis of colorectal cancer through up-regulation the H3K27 crotonylation of ETS1 promoter. Mol Cancer. 2023;22(1):163.","journal-title":"Mol Cancer"},{"issue":"4","key":"2354_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41435-023-00211-0","volume":"24","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhang X, Chen G, Xing Q, Zhu B, Wang X. Integrated analyses reveal the prognostic, immunological features and mechanisms of cuproptosis critical mediator gene FDX1 in KIRC. Genes Immun. 2023;24(4):171\u201382.","journal-title":"Genes Immun"},{"issue":"24","key":"2354_CR28","doi-asserted-by":"publisher","first-page":"e2103240118","DOI":"10.1073\/pnas.2103240118","volume":"118","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Narayanan SP, Mannan R, Raskind G, Wang X, Vats P, Su F, Hosseini N, Cao X, Kumar-Sinha C, et al. Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response. Proc Natl Acad Sci U S A. 2021;118(24):e2103240118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2354_CR29","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","volume":"55","author":"M Meylan","year":"2022","unstructured":"Meylan M, Petitprez F, Becht E, Bougo\u00fcin A, Pupier G, Calvez A, Giglioli I, Verkarre V, Lacroix G, Verneau J, et al. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity. 2022;55(3):527\u2013e541525.","journal-title":"Immunity"},{"issue":"7","key":"2354_CR30","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.17305\/bb.2024.11865","volume":"25","author":"MZ Kocak","year":"2025","unstructured":"Kocak MZ, Araz M, Findik S, Demirkiran A, Korkmaz M, Eryilmaz MK, Artac M. A preliminary study on the prognostic significance of cysteine-rich EGF ligand domain 2 protein (CRELD2) in patients with triple negative breast cancer. Biomol Biomed. 2025;25(7):1663\u201371.","journal-title":"Biomol Biomed"},{"issue":"3","key":"2354_CR31","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1158\/0008-5472.CAN-09-3722","volume":"70","author":"D Huang","year":"2010","unstructured":"Huang D, Ding Y, Li Y, Luo WM, Zhang ZF, Snider J, Vandenbeldt K, Qian CN, Teh BT. Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma. Cancer Res. 2010;70(3):1053\u201362.","journal-title":"Cancer Res"},{"issue":"11","key":"2354_CR32","doi-asserted-by":"publisher","first-page":"101287","DOI":"10.1016\/j.xcrm.2023.101287","volume":"4","author":"X Lu","year":"2023","unstructured":"Lu X, Vano YA, Su X, Helleux A, Lindner V, Mouawad R, Spano JP, Roupr\u00eat M, Comp\u00e9rat E, Verkarre V, et al. Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas. Cell Rep Med. 2023;4(11):101287.","journal-title":"Cell Rep Med"},{"key":"2354_CR33","doi-asserted-by":"publisher","first-page":"1238312","DOI":"10.3389\/fimmu.2023.1238312","volume":"14","author":"Y Yue","year":"2023","unstructured":"Yue Y, Cai X, Lu C, Sechi LA, Solla P, Li S. Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis. Front Immunol. 2023;14:1238312.","journal-title":"Front Immunol"},{"issue":"5","key":"2354_CR34","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s00432-024-05803-5","volume":"150","author":"Z Lin","year":"2024","unstructured":"Lin Z, Xiao S, Qi Y, Guo J, Lu L. Tumor infiltrating B lymphocytes (TIBs) associate with poor clinical outcomes, unfavorable therapeutic benefit and immunosuppressive context in metastatic clear cell renal cell carcinoma (mccRCC) patients treated with anti-PD-1 antibody plus Axitinib. J Cancer Res Clin Oncol. 2024;150(5):262.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"2354_CR35","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Saut\u00e8s-Fridman","year":"2019","unstructured":"Saut\u00e8s-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19(6):307\u201325.","journal-title":"Nat Rev Cancer"},{"issue":"6576","key":"2354_CR36","doi-asserted-by":"publisher","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","volume":"375","author":"TN Schumacher","year":"2022","unstructured":"Schumacher TN, Thommen DS. Tertiary lymphoid structures in cancer. Science. 2022;375(6576):eabf9419.","journal-title":"Science"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02354-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02354-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02354-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T20:02:15Z","timestamp":1788724935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02354-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2354"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02354-y","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the principles of the Declaration of Helsinki. The experimental use of the tissue microarray (Catalog No. HKidE180Su04) was conducted with the approval of the Ethics Committee of Shanghai OUTDO Biotech Co., Ltd (No. SHYHS-CP-240303).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"199"}}